GeneDx Holdings Corp (WGS): Next-Year EPS Estimate 1823.74%
As of 2026-06-11, GeneDx Holdings Corp (WGS) has a next-year EPS growth estimate of 1823.74%.
On 2026-05-07, analyst consensus for WGS's next-year EPS growth shifted from 894.15% to 1823.74% — a positive change of 929.59 percentage points. The revised estimate has been sustained across 26 subsequent trading sessions. Current-year growth is projected at -105.10%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- EPS growth next year
- 1823.74%
- EPS growth this year
- -105.10%
- EPS next quarter (est)
- -$0.19
- Last price
- $60.99
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 1823.74% | -105.10% | -$0.19 | $60.99 |
| 2026-06-10 | 1823.74% | -105.10% | -$0.19 | $54.32 |
| 2026-06-09 | 1823.74% | -105.10% | -$0.19 | $56.33 |
| 2026-06-08 | 1823.74% | -105.10% | -$0.19 | $51.80 |
| 2026-06-07 | 1823.74% | -105.10% | -$0.19 | $52.21 |
| 2026-06-04 | 1823.74% | -105.10% | -$0.19 | $56.27 |
| 2026-06-03 | 1823.74% | -105.10% | -$0.19 | $53.02 |
| 2026-06-02 | 1823.74% | -105.10% | -$0.19 | $53.13 |
| 2026-06-01 | 1823.74% | -105.10% | -$0.19 | $52.00 |
| 2026-05-31 | 1823.74% | -105.10% | -$0.19 | $51.99 |
| 2026-05-28 | 1823.74% | -105.10% | -$0.19 | $50.15 |
| 2026-05-27 | 1823.74% | -105.10% | -$0.19 | $48.21 |
| 2026-05-26 | 1823.74% | -105.10% | -$0.19 | $49.44 |
| 2026-05-25 | 1823.74% | -105.10% | -$0.19 | $47.31 |
| 2026-05-24 | 1823.74% | -105.10% | -$0.19 | $47.31 |
| 2026-05-21 | 1823.74% | -105.10% | -$0.19 | $47.33 |
| 2026-05-20 | 1823.74% | -105.10% | -$0.19 | $44.73 |
| 2026-05-19 | 1823.74% | -105.10% | -$0.19 | $42.13 |
| 2026-05-18 | 1823.74% | -105.10% | -$0.19 | $42.69 |
| 2026-05-17 | 1823.74% | -105.10% | -$0.19 | $40.75 |
| 2026-05-14 | 1823.74% | -105.10% | -$0.19 | $38.85 |
| 2026-05-13 | 1823.74% | -105.10% | -$0.19 | $39.46 |
| 2026-05-12 | 1823.74% | -105.10% | -$0.19 | $39.49 |
| 2026-05-11 | 1823.74% | -105.10% | -$0.19 | $39.61 |
| 2026-05-10 | 1823.74% | -105.10% | -$0.19 | $40.77 |
| 2026-05-07 | 1823.74% | -105.10% | -$0.19 | $40.50 |
| 2026-05-06 | 894.15% | -90.41% | -$0.14 | $34.71 |
| 2026-05-05 | 894.15% | -90.41% | -$0.14 | $34.51 |
| 2026-05-04 | 152.68% | -43.39% | -$0.01 | $67.93 |
| 2026-05-03 | 152.68% | -43.39% | -$0.01 | $65.38 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is GeneDx Holdings Corp's next-year EPS growth estimate?▾
As of 2026-06-11, GeneDx Holdings Corp (WGS) has a next-year EPS growth estimate of 1823.74%, based on analyst consensus.
When was the latest EPS estimate revision for WGS?▾
The most recent revision occurred on 2026-05-07, when analysts adjusted the next-year EPS growth estimate from 894.15% to 1823.74%.
What sector and industry does GeneDx Holdings Corp belong to?▾
GeneDx Holdings Corp operates in the Healthcare sector, specifically the Diagnostics & Research industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. WGS appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. GeneDx Holdings Corp (WGS) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports